Cataract, vitreous hemorrhage, diabetic eye disease, Cerebral small vessel disease, cerebrovascular stenosis, Parkinson's disease, etc.
Conditions
Interventions
Observation group(1.Ocular Data Cohort. 2.Brain Data Cohort,. 3.Eye-Brain Paired Cohort. 4.Clinical Association Cohort.):None
Sponsors
Beijing Friendship Hospital ,Capital Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Eye data: Images must meet quality standards (no significant artifacts, key structures clearly visible), with complete examination records (including examination date and device model); 2.Brain data: MR images must be free of motion artifacts, with complete sequences (at least including T1-weighted imaging and MRA), and reports must confirm no technical issues; 3.Eye-brain paired cohort: Must contain at least one type of eye image (including CFP, OCT, or OCTA) along with brain MR data, and be linkable to a unique identifier and clinical information in the database; 4.Clinical data: Clinical information (such as core biochemical indicators, demographic information, and necessary questionnaire items) must have a missing rate <=30%, with standardized and clear ICD diagnostic codes, complete laboratory test data, and medical order information (including medication or follow-up recommendations); 5.Prior to initial inclusion in the study, participants must have no history of severe organic diseases (including non-curable or end-stage malignancies, severe heart failure (NYHA Class III-IV), end-stage renal disease (CKD Stage 5), decompensated cirrhosis, or significant functional impairment due to severe cerebrovascular disease sequelae, etc.).
Exclusion criteria
Exclusion criteria: 1.Ocular examinations in which key features cannot be identified due to conditions such as cataracts or vitreous hemorrhage brain MR images deemed unacceptable in quality due to factors such as metal implants; 2.Clinical information (including core biochemical indicators, demographic details, essential questionnaire items, etc.) with a missing rate exceeding 30%; 3. Individuals who are pregnant or lactating, those with ocular trauma, congenital ocular malformations, or severe organic diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Eye-Brain Mapping Model Performance;Performance of Systemic Disease Prediction Models;Clinical and Diagnostic Indicators;Strength of association across disease subgroups;Model generalisation capability; | — |
Countries
China
Contacts
Public ContactLv Han
Beijing Friendship Hospital ,Capital Medical University
Outcome results
None listed